Introducing Koala Prospector! Bringing Waterfall Enrichment to Reps

Learn More!
Codiak BioSciences

Codiak BioSciences

Codiak is a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics, a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need. By leveraging the biology of exosomes as natural intercellular transfer mechanisms, Codiak has developed its proprietary engEx Platform to expand upon the innate properties of exosomes to design, engineer and manufacture novel exosome therapeutic candidates. Codiak has utilized its engEx Platform to generate a deep pipeline of engineered exosomes aimed at treating a broad range of disease areas, spanning oncology, neuro-oncology, neurology, and infectious disease.

Last updated on

About Codiak BioSciences

Founded

2015

Estimated Revenue

$10M-$50M

Employees

51-250

Funding / Mkt. Cap

$252M

Category

Industry

Biotechnology

Location

City

Cambridge

State

Massachusetts

Country

United States
Codiak BioSciences

Codiak BioSciences

Find your buyer within Codiak BioSciences

Tech Stack (37)

search